It appears that PPE’s influence on NAFLD extends beyond hepatic factors as it impacts intestinal FXR-FGF15 signaling, offering a multifaceted approach to mitigate the development and progression of this complex metabolic disorder. The gene discussed is NR1H4; the disease is metabolic disease.